Psychiatry - Amyloid in the Retina Correlates With Alzheimer's Brain Changes
Researchers have identified amyloid in the retina of living patients with cognitive decline and correlated this with brain changes. Medscape Medical News
View ArticlePsychiatry - People with Parkinson's disease at increased risk for suicide
Individuals with Parkinson's disease were at increased risk for suicide, according to results of a nationwide population-based cohort study published in JAMA...
View ArticlePsychiatry - Top psych stories 2020: Sleep loss and Alzheimer's risk,...
As 2020 draws to a close, Healio Psychiatry has compiled a list of the most-read stories of the year for psychiatrists and other mental health professionals. A study on the...
View ArticlePsychiatry - Cognitive impairment may worsen with menopause stage
A cohort of women with and without HIV experienced declines in three cognitive domains associated with menopause stage, independent of age and other factors, according to...
View ArticlePsychiatry - Researchers demonstrate great potential for blood test to...
In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house...
View ArticlePsychiatry - Little Help, Possible Harm of Antidepressants for Pain
A new review suggests that the benefits of antidepressants for back pain and osteoarthritis are limited. Medscape Medical News
View ArticlePsychiatry - Cannabinoids 'Worth a Try' for Agitation in Alzheimer's
THC, the psychoactive agent in cannabinoids, may provide an alternative to off-label use of antipsychotics and other medications to manage agitation in patients with...
View ArticlePsychiatry - Early Motor Signal Specific to Alzheimer's Identified
Gait abnormalities can herald cognitive impairments in neurodegenerative conditions, especially Alzheimer's disease. Medscape Medical News
View ArticlePsychiatry - Alzheimer's Association Denies Conflict in Aducanumab Support
The Alzheimer's Association denies accusations that its repeated endorsement of aducanumab, a drug under FDA review for Alzheimer's, has been unduly influenced by financial...
View ArticlePsychiatry - Portable Brain Stimulator May Cut Agitation in Alzheimer's
A small portable device that delivers transcranial stimulation may be safe and effective in helping to reduce agitation for patients with Alzheimer's, early research...
View ArticlePsychiatry - Cancer Drug Promising for Alzheimer's Disease
In a small phase 2 trial, GM-CSF/sargramostim provided measurable disease-modifying and memory-enhancing benefits in patients with mild-to-moderate Alzheimer's...
View ArticlePsychiatry - Five-Minute Digital Clock Test May Speed Alzheimer's Diagnosis
A digital version of the classic clock-drawing test, which can be completed in under 5 minutes, accurately detects the beginnings of dementia. Results correlating with amyloid...
View ArticlePsychiatry - Depression in older adults undergoing hip surgery increases...
Depressive symptoms were associated with underlying Alzheimer's disease pathology and postoperative delirium in older adults who underwent hip fracture repair, according to a...
View ArticlePsychiatry - Psychosis, Depression Tied to Neurodegeneration in Parkinson's
Depression and psychosis are significantly associated with neuronal loss and gliosis, but not with Lewy body scores, in Parkinson's disease, new research suggests. Medscape...
View ArticlePsychiatry - Data collected via smartphones, wearables may help personalize...
A digital data-driven approach was able to predict depression and allow for personalized treatment, according to study results published in Translational Psychiatry. “There are...
View ArticlePsychiatry - OCD increases risk for any dementia, Alzheimer's disease
Obsessive-compulsive disorder independently increased risk for subsequent dementia, including Alzheimer's disease and vascular dementia, according to results of a nationwide...
View ArticlePsychiatry - Neurodegeneration Complicates Psychiatric Care in Parkinson's
While the exact mechanism for depression and anxiety's link to Parkinson's disease is unknown, both occur with increased prevalence across the disease course, experts...
View ArticlePsychiatry - FDA Fast-Tracks Lecanemab for Alzheimer's Disease
The FDA has granted breakthrough therapy designation to lecanemab , an investigational anti-amyloid beta protofibril antibody for the treatment of Alzheimer's disease. Medscape...
View ArticlePsychiatry - Top psych stories of June: Cannabis and neurodevelopment, OCD...
Healio Psychiatry has compiled a list of its five most-viewed stories in June. A study on the association between OCD and increased risk for any dementia/Alzheimer's disease...
View ArticlePsychiatry - FDA Updates Label for Controversial Alzheimer's Drug Aduhelm
The new label emphasizes that the drug should only be initiated in patients with mild cognitive impairment as a result of Alzheimer's disease or mild dementia stage of...
View Article
